Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) fell 1.2% during mid-day trading on Thursday . The company traded as low as $3.6750 and last traded at $3.6750. Approximately 7,960 shares traded hands during mid-day trading, a decline of 40% from the average session volume of 13,304 shares. The stock had previously closed at $3.72.
Medexus Pharmaceuticals Trading Down 1.2%
The firm has a 50-day simple moving average of $3.52 and a 200 day simple moving average of $2.91.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
